Determination of (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate in rat plasma by RP-HPLC
doi: 10.3969/j.issn.1006-0111.2012.01.011
- Received Date: 2011-04-08
- Rev Recd Date: 2011-11-06
-
Key words:
- (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate /
- HPLC /
- plasma concentration /
- Pharmacokinetics
Abstract: Objective To establish a method for determination of (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate in plasma of SD rats by RP-HPLC. Methods The chromatographic separation was performed on a Diamonsil-C18 column(100 mm×4.6 mm,5 μm) with the mobile phase consisting of acetonitrile/5 mM ammonium acetate buffer(pH 4.0)(30/70,v/v). The single intravenous injection of (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate was given to 70 SD rats to study the pharmacokinetics. Results The intra-run and inter-run RSD were less than 15%. The pharmacokinetics parameters were as follows: Cmax was 35.60 μg/ml , t1/2 was 3.36 h, AUC0~12 was 17.12 μg h/ml, AUC0~∞ was 17.72μg h/ml. Conclusion The method was simple and accurate, which could be used to separation and determination of (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate.
Citation: | DOU Ying-Hui, WANG Li, HE Guang-Wei, WU Qiang, FAN Guo-Rong, HANG Tai-Jun. Determination of (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate in rat plasma by RP-HPLC[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(1): 42-44,48. doi: 10.3969/j.issn.1006-0111.2012.01.011 |